Disease/Infection News

RSS

MitoSciences awarded $590,000 to support development of companion diagnostic tests for antiviral drugs

MitoSciences announces that it has just been awarded $590,000 by the National Institutes of Health to support the development of companion diagnostic tests for antiviral drugs. The award was made after competitive scientific review and was issued under The American Recovery and Reinvestment Act of 2009.

14 May 2010

HIV disease tends to progress at faster rate in infected individuals who consume more alcoholic drinks

HIV disease tends to progress at a faster rate in infected individuals who consume two or more alcoholic drinks a day, according to an important new paper in AIDS Research and Human Retroviruses, a peer-reviewed journal published by Mary Ann Liebert, Inc.

14 May 2010

Chimerix commences first-in-human study of CMX157 for HIV

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced the commencement of a first-in-human study of CMX157, a novel lipid conjugate of the nucleotide tenofovir with in vitro activity against both tenofovir-sensitive and tenofovir-resistant human immunodeficiency virus (HIV). CMX157 has the potential to increase efficacy and decrease toxicity as compared to tenofovir, and may enable the creation of new 'one pill, once-a-day', fixed-dose combination regimens for the treatment of HIV infection.

14 May 2010

Gene-Eden may be effective in reducing Hepatitis C viral load in people infected with virus: Review

A new review on the Amazon website suggests that the natural antiviral supplement Gene-Eden may be effective in reducing the Hepatitis C viral load in people infected with the virus.

13 May 2010

Genetic Immunity formulates first topically administered nanomedicine therapeutic vaccine for HIV/AIDS

Genetic Immunity, a multi-national biopharmaceutical company developing nanomedicine vaccines today announces publication of the Company's innovative work to develop a stable liquid formulation to deliver a novel nanomedicine. Appearing in the International Journal of Pharmaceutics, the paper addresses how Genetic Immunity was able to overcome significant hurdles facing the field to successfully formulate the first topically administered nanomedicine therapeutic vaccine for the treatment of HIV/AIDS, DermaVir.

13 May 2010

Increased IR associated with HCC development in chronic HCV-infected patients

Recent studies have demonstrated that type 2 diabetes mellitus (DM) is associated with high risk of hepatocellular carcinoma (HCC) development in patients with chronic hepatitis C. Insulin resistance (IR), which correlates inversely with circulating adiponectin concentration, is a consistent finding in patients with type 2 DM.

13 May 2010

27-year-old sickle cell disease patient undergoes multiple joint replacement surgery

Fortis Hospitals Mulund, Mumbai, performed a multiple joint replacement surgery on a 27 year old young Nigerian patient. Rebacca underwent a hip and a shoulder replacement surgery by Dr. Sachin Bhonsle, Consultant Orthopedic Surgeon, after years of suffering in pain and immobility.

13 May 2010

Celera to present on AIDS pandemic, AZT drugs at Computational Molecular Biology Symposium

In 1985 there was little hope for people with AIDS. Newspapers and television screens were filled with ghastly pictures of emaciated figures dying from a disease that had no cure.

13 May 2010

Pacific Island region on track to meet TB MDG, drug-resistance remains a threat

Experts at the Fifth Pacific Stop Tuberculosis Meeting in Nadi, Fiji, concluded that the Pacific Islands region is on track to meet the Millennium Development Goal of halving TB prevalence by 2015, All Headline News reports in an article about the meeting, which recently concluded.

13 May 2010

AHF targets BMS over pricing and policies for its HIV/AIDS drug

AIDS Healthcare Foundation will host a protest Wednesday morning, May 12th at 10:30am targeting New York-based Bristol Myers Squibb Co. over the pricing and policies for its key HIV/AIDS drug, Reyataz, one of the most expensive first-line AIDS treatment in the US, during the Bank of America-Merrill Lynch 2010 Health Care Conference.

13 May 2010

U.S. expands HIV/AIDS programs in Caribbean

Representatives from the U.S. and Caribbean Community (CARICOM) on Tuesday signed an agreement to expand PEPFAR programs to 12 other Caribbean nations during a gathering in Georgetown, Guyana, Agence France-Presse reports (5/11).

13 May 2010

Microbiologists identify potential target in cattle to prevent E. coli strain

Microbiologists at UT Southwestern Medical Center, working with the Department of Agriculture, have identified a potential target in cattle that could be exploited to help prevent outbreaks of food-borne illnesses caused by a nasty strain of Escherichia coli.

13 May 2010

HIV caseload increasing among primary care providers

Primary care providers (PCPs) are increasingly caring for and treating people living with HIV, according to the HealthHIV State of HIV Primary Care survey released today.

12 May 2010

NIH awards PLx Pharma multiple grants for development of GI safer NSAIDs

PLx Pharma, a pharmaceutical company developing safer formulations of proven non-steroidal anti-inflammatory drugs (NSAIDs), today announced that it has been awarded multiple grants from the National Institutes of Health (NIH) totaling approximately $2,000,000. This funding has been awarded to support further advancement of a range of products currently under development by PLx.

12 May 2010

MRSA Survivors Network to raise awareness on MRSA infections

More Americans die annually from invasive methicillin-resistant Staphylococcus aureus infections than from HIV/AIDS, H1N1 influenza and Parkinson's disease, yet the United States and many other countries' health officials continue to ignore the global crisis.

12 May 2010

Giardia's surface proteins may work as vaccines to help prevent infections: Research scholar

The intestinal parasite Giardia lamblia changes outfits nearly as often as a fashion model on a Parisian runway. With more than 200 protein coats in its molecular wardrobe, this troublesome creature-the cause of innumerable cases of diarrheal infections each year-can change its appearance from one instant to the next, throwing the body's immune cells off track.

12 May 2010

Preventable infectious diseases cause two-thirds of child deaths: The Lancet

Preventable infectious diseases cause two-thirds of child deaths, according to a new study published today by The Lancet. Experts from the World Health Organization and UNICEF's Child Health Epidemiology Reference Group assessed data from 193 countries to produce estimates by country, region and the world.

12 May 2010

Mutation causing light chain amyloidosis identified

Light chain amyloidosis, a deadly protein misfolding disease, is caused by multiple mutations in cells that are intended to protect the body. Instead, the mutations send misfolded bundles of proteins through the bloodstream, potentially destroying the heart, kidneys, liver or other organs. Mayo Clinic researchers have identified one of these mutations and have shown that the molecule's shifting position is as important as its unique shape. The findings appear in the current issue of the journal Structure.

12 May 2010

Periodontal disease treatment reduces blood sugar levels in Type 2 diabetes patients

A study to be published in the latest issue of The Cochrane Library and led by researchers at the University of Edinburgh and supported by colleagues at the Peninsula Dental School, the University of Ottawa and UCL Eastman Dental Institute, suggests that the treatment of serious gum (periodontal) disease in diabetics with Type 2 diabetes may lower their blood sugar levels.

12 May 2010

MIT featured in U.S. Equity News

Micro Identification Technologies, Inc., a leader in rapid bacterial identification, today announces it was recently featured in an editorial published by U.S. Equity News that covers the history of bacteria, its life threatening effects, and publicly traded companies leading the fight against harmful bacteria.

12 May 2010

Disease/Infection News

MitoSciences awarded $590,000 to support development of companion diagnostic tests for antiviral drugs

HIV disease tends to progress at faster rate in infected individuals who consume more alcoholic drinks

Chimerix commences first-in-human study of CMX157 for HIV

Gene-Eden may be effective in reducing Hepatitis C viral load in people infected with virus: Review

Genetic Immunity formulates first topically administered nanomedicine therapeutic vaccine for HIV/AIDS

Increased IR associated with HCC development in chronic HCV-infected patients

27-year-old sickle cell disease patient undergoes multiple joint replacement surgery

Celera to present on AIDS pandemic, AZT drugs at Computational Molecular Biology Symposium

Pacific Island region on track to meet TB MDG, drug-resistance remains a threat

AHF targets BMS over pricing and policies for its HIV/AIDS drug

U.S. expands HIV/AIDS programs in Caribbean

Microbiologists identify potential target in cattle to prevent E. coli strain

HIV caseload increasing among primary care providers

NIH awards PLx Pharma multiple grants for development of GI safer NSAIDs

MRSA Survivors Network to raise awareness on MRSA infections

Giardia's surface proteins may work as vaccines to help prevent infections: Research scholar

Preventable infectious diseases cause two-thirds of child deaths: The Lancet

Mutation causing light chain amyloidosis identified

Periodontal disease treatment reduces blood sugar levels in Type 2 diabetes patients

MIT featured in U.S. Equity News

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News